Reviva Pharmaceuticals Holdings, Inc. Share Price
Equities
RVPH
US76152G1004
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.99 USD | +0.34% | -0.99% | -41.94% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 83.48M 6.96B |
---|---|---|---|---|---|
Net income 2024 * | -37M -3.08B | Net income 2025 * | -43M -3.59B | EV / Sales 2024 * | - |
Net cash position 2024 * | 39.9M 3.33B | Net cash position 2025 * | 31.9M 2.66B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.4
x | P/E ratio 2025 * |
-2.27
x | Employees | 15 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.23% |
1 day | +0.34% | ||
1 week | -0.99% | ||
Current month | -20.90% | ||
1 month | -23.33% | ||
3 months | -22.74% | ||
6 months | -20.27% | ||
Current year | -41.94% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 11/20/11 | |
Narayan Prabhu
DFI | Director of Finance/CFO | 53 | 14/20/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 69 | 14/20/14 | |
Les Funtleyder
BRD | Director/Board Member | 55 | 14/20/14 |
Founder | 59 | 11/20/11 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 2.99 | +0.34% | 116,230 |
25/24/25 | 2.98 | -1.32% | 107,227 |
24/24/24 | 3.02 | -1.31% | 78,687 |
23/24/23 | 3.06 | -0.97% | 77,792 |
22/24/22 | 3.09 | +2.32% | 111,561 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.94% | 83.48M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- RVPH Stock